Inovia Bio

Drug-development strategy, evidence generation and AI platforms for biotech and pharma development teams, priced per outcome

London, United KingdomFounded 2022inovia.bioWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2022
  • New on EvolcAdded 2026-11-03

About Inovia Bio

Inovia Bio is a techbio company that provides drug-development strategy and evidence generation. Its offer combines advisory and clinical development services with its own platforms: InovaMine, which turns a customer's dataset and SAP into submission-grade tables, and Falcon, which it describes as PhD-level AI employees. Services include clinical development, strategic advisory, integrated evidence plans (IEP/IEGP) and real-world evidence.

Customers are drug development teams. Engagements are fixed-scope projects, programme partnerships, or embedded and rescue retainers, priced to outcomes and agreed upfront with no change orders.

The company was founded in 2022 and is headquartered in London, United Kingdom. Its co-founders are Imi Faghmous (CSO) and Antonio Nicolae (CTO), and it lists several senior advisors. The company states that it can complete an entire IEP/IEGP in 10 days.

Product: Outcomes-priced drug-development advisory and evidence services, plus the InovaMine and Falcon AI platforms.

Jobs at Inovia Bio

No open positions listed right now.

More biotech & pharma companies

  • Invox Pharma

    Develops respiratory medicines and soft-mist inhaler products for patients and pharmaceutical partners
    London, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Ipsen

    Develops and sells medicines in oncology, rare diseases and neuroscience for patients and healthcare professionals
    London, United KingdomBiotech & pharmaFounded 2008177 open jobs
    New on Evolc
  • Isomorphic Labs

    AI-driven drug discovery platform building predictive and generative models for pharmaceutical research and development
    London, United KingdomBiotech & pharmaFounded 202132 open jobs
    Remote-friendly
  • Istesso

    Develops oral mitochondrial Complex I modulator medicines to restore tissue repair; lead candidate leramistat is in Phase 2
    London, United KingdomBiotech & pharmaFounded 2017
    New on Evolc
  • Itf Pharma

    Rare-disease pharmaceutical company developing treatments for Duchenne muscular dystrophy in the UK and Ireland
    London, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Janssen-Cilag

    Medicines and medical technologies for patients, healthcare professionals and healthcare systems
    Buckinghamshire, United KingdomBiotech & pharmaFounded 197119 open jobs
    New on EvolcSalary transparent

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • HubSpot CMSMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.